Gene: SCYGR4
Official Full Name: small cysteine and glycine repeat containing 4provided by HGNC
Gene Summary: Predicted to be located in intermediate filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14292 | SCYGR4 Knockout cell line (HeLa) | Human | SCYGR4 | 1:3~1:6 | Negative | Online Inquiry |
KO14293 | SCYGR4 Knockout cell line (HCT 116) | Human | SCYGR4 | 1:2~1:4 | Negative | Online Inquiry |
KO14294 | SCYGR4 Knockout cell line (A549) | Human | SCYGR4 | 1:3~1:4 | Negative | Online Inquiry |
SCYGR4 Gene Knockout Cell Lines are specially engineered cell lines that feature the deliberate disruption or inactivation of the SCYGR4 gene. This genetic modification is achieved through advanced techniques such as CRISPR-Cas9 or other gene-editing technologies, allowing researchers to explore the functional implications of SCYGR4 in various biological contexts. By removing the SCYGR4 gene, these cell lines provide a powerful tool for studying gene function, cellular signaling pathways, and the physiological consequences of gene loss.
The primary function of SCYGR4 Gene Knockout Cell Lines is to facilitate detailed investigations into the role of the SCYGR4 gene in cellular processes, including growth, differentiation, and response to environmental stimuli. Scientists can employ these knockout lines to identify the mechanisms by which SCYGR4 influences cellular behavior and how its dysregulation might contribute to disease pathologies. The resultant data can significantly advance our understanding of diseases such as cancer, where gene regulation often plays a critical role.
From a scientific standpoint, these cell lines are indispensable in both research and clinical applications. They enable researchers to delineate the pathways influenced by SCYGR4, offering insights into potential therapeutic targets and biomarkers. Furthermore, their utility extends to drug discovery, where identifying gene interactions is key to developing novel treatments.
What sets SCYGR4 Gene Knockout Cell Lines apart from alternatives is their robustness and reliability, stemming from rigorous validation processes. Unlike conventional knockout methods, these cell lines provide a consistent and reproducible platform that enhances experimental accuracy. Researchers benefit from data generated with these lines due to their high fidelity and controlled genetic background, simplifying comparative analyses.
For researchers and clinicians alike, SCYGR4 Gene Knockout Cell Lines represent a transformative asset, opening avenues for innovative research and promising clinical interventions. Their ability to unravel complex biological pathways marks them as powerful tools in advancing the fields of genetics and molecular biology.
As a leading provider in the field of biological products, our company is committed to delivering high-quality and validated research tools that empower scientists to achieve their goals. Our expertise ensures that every product, including the SCYGR4 Gene Knockout Cell Lines, meets the highest standards of reliability and performance, making us a trusted partner in scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.